These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33960697)

  • 1. The efficacy of radiofrequency ablation versus cryoablation in the treatment of single hepatocellular carcinoma: A population-based study.
    Chen L; Ren Y; Sun T; Cao Y; Yan L; Zhang W; Ouyang T; Zheng C
    Cancer Med; 2021 Jun; 10(11):3715-3725. PubMed ID: 33960697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of percutaneous ethanol injection versus radiofrequency ablation for single hepatocellular carcinoma no larger than 5 cm.
    Yang P; Li N
    J Int Med Res; 2022 Jul; 50(7):3000605221111281. PubMed ID: 35861264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of surgery in advanced hepatocellular carcinoma: a cohort study.
    Chen L; Sun T; Chen S; Ren Y; Yang F; Zheng C
    World J Surg Oncol; 2020 Jun; 18(1):119. PubMed ID: 32487104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency Ablation
    Xu J; Noda C; Erickson A; Mokkarala M; Charalel R; Ramaswamy R; Tao YU; Akinwande O
    Anticancer Res; 2018 Nov; 38(11):6381-6386. PubMed ID: 30396961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Survival Between First-Line Radiofrequency Ablation versus Surgery for Early-Stage Hepatocellular Carcinoma: A Population Study Using the Surveillance, Epidemiology, and End Results Database.
    Lin Y; Pan XB
    Med Sci Monit; 2020 May; 26():e921782. PubMed ID: 32461542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma.
    Wang C; Wang H; Yang W; Hu K; Xie H; Hu KQ; Bai W; Dong Z; Lu Y; Zeng Z; Lou M; Wang H; Gao X; Chang X; An L; Qu J; Li J; Yang Y
    Hepatology; 2015 May; 61(5):1579-90. PubMed ID: 25284802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation versus surgical resection in elderly patients with early-stage hepatocellular carcinoma in the era of organ shortage.
    Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
    Saudi J Gastroenterol; 2018; 24(6):317-325. PubMed ID: 30117492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efficacy of Surgical Resection versus Radiofrequency Ablation for the Treatment of Single Hepatocellular Carcinoma: A SEER-Based Study.
    Wu F; Wei C; Zhang S; Jia S; Zhang J
    Gastroenterol Res Pract; 2023; 2023():1269504. PubMed ID: 36865983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma ≤ 4 cm treated with radiofrequency ablation with or without percutaneous ethanol injection.
    Shi F; Tan Z; An H; Wang X; Xu Y; Wang S
    Ann Hepatol; 2016; 15(1):61-70. PubMed ID: 26626642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC ≤ 3 cm: A propensity score-matched study.
    Wang X; Yu H; Zhao F; Xu Y; Wang C; Liu K; Liu B; Zheng H; Wei Y; Wang X; Zhu Q; Huang M; Feng Y
    Eur J Radiol; 2023 Jul; 164():110860. PubMed ID: 37178491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma.
    Kim N; Kim HJ; Won JY; Kim DY; Han KH; Jung I; Seong J
    Radiother Oncol; 2019 Feb; 131():81-87. PubMed ID: 30773192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
    Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
    BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical resection versus radiofrequency ablation very early-stage HCC (≤2 cm Single HCC): A propensity score analysis.
    Chu HH; Kim JH; Kim PN; Kim SY; Lim YS; Park SH; Ko HK; Lee SG
    Liver Int; 2019 Dec; 39(12):2397-2407. PubMed ID: 31549771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison among cryoablation, radiofrequency ablation, and partial nephrectomy for renal cell carcinomas sized smaller than 2 cm or sized 2-4 cm: A population-based study.
    Yan S; Yang W; Zhu CM; Yan PM; Wang ZC
    Medicine (Baltimore); 2019 May; 98(21):e15610. PubMed ID: 31124938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.